Trial
NCT04643405
APG-1387 Plus Chemotherapy in Advanced Pancreatic Adenocarcinoma
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Ascentage Pharma Group Inc.
Collaborators
—
Condition
Advanced Pancreatic Cancer
Intervention
APG-1387 for Injection
Why stopped
Company Strategy
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-01-08